Cyprus vs Marshall Islands: The number of people with susceptibility test result for rifampicin
Cyprus
29
in 2021
Marshall Islands
31
in 2021
Cyprus rank
128th
Marshall Islands rank
127th
The number of people with susceptibility test result for rifampicin over time
- Cyprus
- Marshall Islands
How they compare
Marshall Islands currently reports 31 against 29 in Cyprus, a difference of 2.
That makes Marshall Islands's figure about 1.1 times Cyprus's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Marshall Islands ahead.
Cyprus ranks 128th and Marshall Islands ranks 127th of 155 countries.
Across the 2 decades both report, Cyprus averaged higher in 1 and Marshall Islands in 1.
Head to head by decade
| Decade | Cyprus | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 37.67 | 54 | 16.33 | Marshall Islands |
| 2020s | 27 | 25.5 | 1.5 | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cyprus or Marshall Islands?
- Marshall Islands, at 31 against 29 in Cyprus as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cyprus and Marshall Islands?
- 2, with Marshall Islands ahead.
- How many years of comparable data are there for Cyprus and Marshall Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Cyprus and Marshall Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Cyprus ranks 128th and Marshall Islands ranks 127th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.